Table 3.
Multivariate analysis for overall survival of clinical and lung function parameters.
| Hazard ratios for overall survival | ||||
|---|---|---|---|---|
| n | HR | 95% CI | p value | |
| FEV1 < 70% of predicted | 18 | 2.47 | 1.20, 5.06 | 0.02 |
| DLCOc SB < 60% of predicted | 35 | 1.87 | 1.15, 3.03 | 0.02 |
| Karnofsky index ≤ 80% | 92 | 1.70 | 1.11, 2.58 | 0.02 |
| HCT-CI score liver | 51 | 1.69 | 1.04, 2.74 | 0.03 |
| Age < 55 years | 63 | 0.51 | 0.30, 0.88 | 0.02 |
| Conditioning with FTM | 105 | 1.31 | 0.85, 2.58 | 0.21 |
Clinical factors (Supplementary Table 2) with a p value < 0.1 in univariate analysis were included in the multivariate analysis with conditioning protocol as hypothesis covariate. Multivariate analysis following backward selection was performed using the Cox proportional hazards regression model.
HCT-CI hematopoietic cell transplantation comorbidity index, DLCOcSB diffusion capacity of carbon monoxide adjusted for hemoglobin level, FEV1 forced expiratory volume in 1s, HR hazard ratios, CI confidence intervals, FTM fludarabine, thiotepa, melphalan.